Hot Topics (and Hot Chilis): SABCS 2017
Dr Kathy Miller highlights potential practice-changing studies that she is looking forward to at SABCS 2017. (Source: Medscape Oncology)
Source: Medscape Oncology - December 5, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Epacadostat + Pembro for Melanoma: Beneficial, Well Tolerated
This combination produced impressive response and disease control rates with good tolerability in treatment-naive patients with advanced melanoma. (Source: Medscape Oncology)
Source: Medscape Oncology - November 30, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Prostate Cancer Care Is 'Changing Rapidly': ESMO 2017
Exciting research presented at ESMO 2017 will likely affect clinical practice in metastatic prostate cancer, says Dr Johann de Bono. (Source: Medscape Oncology)
Source: Medscape Oncology - November 17, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Improved Insurance Access Increases Elective Colon Resection Rates
A new analysis proves that the Massachusetts health insurance ' experiment ' resulted in better cancer care. (Source: Medscape Oncology)
Source: Medscape Oncology - November 16, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Stage III CRC: Which Patients Need 6 Months of Adjuvant Chemo?
At the ESMO 2017 Congress in Madrid, Drs Sobrero and Taieb discuss the optimal duration of adjuvant chemotherapy for stage III colon cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - November 16, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Combination Therapies: A Tipping Point for Cancer Drug Costs?
Combination treatments are escalating already urgent questions about the cost and value of new cancer drugs. (Source: Medscape Oncology)
Source: Medscape Oncology - November 9, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
ESMO's Practice-Changing Lung Cancer Data: Three Experts Discuss
At ESMO 2017, Jack West discussed new, potentially practice-changing immunotherapy research with Hossein Borghaei and Sanjay Popat. (Source: Medscape Oncology)
Source: Medscape Oncology - November 6, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Immunotherapy for Lung Cancers: First-Line and Beyond
Drs West, Garon, and Borghaei discuss immunotherapy for selected lung cancers and the potential roles and pitfalls of combination immunotherapy. (Source: Medscape Oncology)
Source: Medscape Oncology - November 3, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
An Urgent Plea to Oncologists for HPV Vaccination
Oncologists fail to recommend HPV vaccination to young cancer survivors, even though it is a safe and effective cancer prevention strategy. (Source: Medscape Oncology)
Source: Medscape Oncology - November 2, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
'Dealing With the Hype': Communicating and the Art of Oncology
Dealing with the hype has to do with putting accurate information on the table for discussion, getting rid of the taboos of conversation, and increasing transparency, says Dr Leonard Saltz. (Source: Medscape Oncology)
Source: Medscape Oncology - November 2, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Adjuvant BRAF and MEK Inhibition for Melanoma: 'Impressive'
New at ESMO 2017, adjuvant dabrafenib/trametinib in stage III melanoma shows ' impressive ' results in relapse-free survival. (Source: Medscape Oncology)
Source: Medscape Oncology - October 31, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
'Important' Progress in Gynecologic Cancers: ESMO 2017
Dr Banerjee discusses advances in ovarian and cervical cancers presented at ESMO 2017. (Source: Medscape Oncology)
Source: Medscape Oncology - October 30, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Durvalumab After Chemoradiotherapy 'Immediately Changes Practice'
Clinical trial data from ESMO 2017 have immediate clinical implications for the treatment of locally advanced lung cancers, according to Dr Mark Kris. (Source: Medscape Oncology)
Source: Medscape Oncology - October 27, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Clinical Trials Are 'Too Damn Complicated'
Simplifying clinical research is possible and desirable, says Dr John Marshall. (Source: Medscape Oncology)
Source: Medscape Oncology - October 26, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Rules of Thumb for Incorporating Alternative Therapies
Traditional Chinese medicine and other alternative therapies have a lot to offer patients with cancer, says Dr Kerr. Just follow three simple ' rules ' when choosing. (Source: Medscape Oncology)
Source: Medscape Oncology - October 26, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
